Genetic causes of PD: A pathway to disease modification
- PMID: 32119885
- DOI: 10.1016/j.neuropharm.2020.108022
Genetic causes of PD: A pathway to disease modification
Abstract
The underline neuropathology of Parkinson disease is pleiomorphic and its genetic background diverse. Possibly because of this heterogeneity, no effective disease modifying therapy is available. In this paper we give an overview of the genetics of Parkinson disease and explain how this is relevant for the development of new therapies. This article is part of the special issue entitled 'The Quest for Disease-Modifying Therapies for Neurodegenerative Disorders'.
Keywords: Disease modifying; GBA1; Genetics; LRRK2; Parkinson disease; SNCA; Therapy.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous